Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00005098|
Recruitment Status : Terminated
First Posted : April 7, 2000
Last Update Posted : June 24, 2005
I. Establish cell lines from patients with alpha 1-antitrypsin deficiency in order to examine genetic traits that predispose to liver injury.
|Condition or disease|
|Alpha 1-Antitrypsin Deficiency|
Patients undergo blood draw and skin biopsy. Cells are isolated from patients' blood and skin, cell lines are established, and genetic traits are examined.
|Study Type :||Observational|
|Estimated Enrollment :||160 participants|
|Study Start Date :||March 1999|
U.S. FDA Resources
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00005098
|United States, Pennsylvania|
|Children's Hospital of Pittsburgh|
|Pittsburgh, Pennsylvania, United States, 15213|
|Study Chair:||David H. Perlmutter||University of Pittsburgh|